Future asthma guidelines need to focus more on the unmet needs of the patients whose severe asthma is not well controlled, said Tonya Winders, MBA, CEO and president of the Allergy & Asthma Network.
Future asthma guidelines need to focus more on the unmet needs of the patients whose severe asthma is not well controlled, said Tonya Winders, MBA, CEO and president of the Allergy & Asthma Network, who spoke at the European Respiratory Society meeting.
Transcript
How do asthma guidelines affect the day-to-day experience of patients with asthma?
Winders: Well, the asthma guidelines definitely outline what is the standard of care, the clinical pathway that a patient should expect when they are diagnosed and then when they are reassessed on an ongoing basis by their provider. Unfortunately, there's a disconnect between what should happen and what often does. And so, that's what really [my] session will highlight. And again, we will bring to bear patient experience, patient voice, and exactly what some of those barriers may be.
Does the experience differ on the degree of asthma severity?
Winders: The experience of patients of mild asthma vs moderate-to-severe asthma is very different. When it comes to daily impairment and impact on activities of daily living, it's very evident that the severe asthma population has the bulk of the unmet need and burden. And so, there is a disparity difference between those three, of mild, moderate, and severe. But even within the severe population, we see a vast difference between those that are uncontrolled, and those that are well controlled. So, really, the focus needs to be on the unmet needs of the area of those with poorly-controlled severe asthma most evidently.
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Early Detection Strategies for Interstitial Lung Disease in Rheumatology: Janet Pope, MD, MPH
August 11th 2025Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic sclerosis, rheumatoid arthritis, and other connective tissue diseases.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More